Eli Lilly has chosen a leading USA-approved GMP provider to supply its groundbreaking medications, Retatrutide and Tirzepatide. This strategic decision demonstrates Lilly's commitment to excellence in manufacturing and ensures patients with access to safe and effective treatments. The chosen partner possesses a strong track record of meeting string